Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic Migraine
Public ClinicalTrials.gov record NCT03912337. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic Migraine Who Have Previously Failed 1 or More Migraine Preventive Treatments.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the effect of erenumab compared to placebo on disability in employed subjects with episodic migraine (EM) who have previously failed 1 or more migraine preventive treatments.
Study identification
- NCT ID
- NCT03912337
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 29 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 3, 2019
- Primary completion
- Jul 27, 2021
- Completion
- Jul 27, 2021
- Last update posted
- Jul 19, 2022
2019 – 2021
United States locations
- U.S. sites
- 28
- U.S. states
- 18
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | 35235 | — |
| Research Site | Huntsville | Alabama | 35805 | — |
| Research Site | Los Angeles | California | 90094 | — |
| Research Site | Pasadena | California | 91105 | — |
| Research Site | Basalt | Colorado | 81621 | — |
| Research Site | East Hartford | Connecticut | 06118 | — |
| Research Site | New London | Connecticut | 06320 | — |
| Research Site | Stamford | Connecticut | 06905 | — |
| Research Site | Jacksonville | Florida | 32216 | — |
| Research Site | Orlando | Florida | 32806 | — |
| Research Site | Chalmette | Louisiana | 70043 | — |
| Research Site | Hagerstown | Maryland | 21742 | — |
| Research Site | Worcester | Massachusetts | 01605 | — |
| Research Site | Ann Arbor | Michigan | 48104 | — |
| Research Site | Minneapolis | Minnesota | 55402 | — |
| Research Site | Bolivar | Missouri | 65613 | — |
| Research Site | City of Saint Peters | Missouri | 63303 | — |
| Research Site | Springfield | Missouri | 65810 | — |
| Research Site | St Louis | Missouri | 63141 | — |
| Research Site | Toms River | New Jersey | 08755 | — |
| Research Site | Durham | North Carolina | 27713 | — |
| Research Site | Greensboro | North Carolina | 27405 | — |
| Research Site | Centerville | Ohio | 45459 | — |
| Research Site | Philadelphia | Pennsylvania | 19107 | — |
| Research Site | Nashville | Tennessee | 37203 | — |
| Research Site | Austin | Texas | 78731 | — |
| Research Site | Frisco | Texas | 75034 | — |
| Research Site | Salt Lake City | Utah | 84109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03912337, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 19, 2022 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03912337 live on ClinicalTrials.gov.